Structure Therapeutics Inc. / Fundamentals
Income statement
- Net revenue
€0.00 - Cost of goods sold
€737.03K - Gross profit
-€737.03K - SG&A expenses
€47.64M - R&D expenses
€141.41M - EBITDA
-€180.62M - D&A
€1.44M - EBIT
-€189.79M - Interest expenses
€0.00 - EBT
-€154.23M - Tax expenses
€401.73K - Net income
-€154.63M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€14.18M - Changes in working capital
€8.15M - Operating cash flow
-€140.63M - Capex
€1.08M - Other investing cash flow
€58.57M - Net investing cash flow
-€62.86M - Total cash dividends paid
€0.00 - Issuance of common stock
-€444.30M - Debt repayment
€0.00 - Other financing cash flow
€573.69K - Net financing cash flow
€1.02M - Foreign exchange effects
€0.00 - Net change in cash
-€202.47M - Cash at end of period
€126.89M - Free cash flow
-€139.56M
Balance sheet
- Cash and cash equivalents
€126.89M - Cash and short-term investments
€678.79M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€11.05M - Total current assets
€689.83M - Property, plant & equipment
€9.44M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€5.35M - Total non-current assets
€14.80M - Total assets
€704.63M - Accounts payable
€7.76M - Short-term debt
€4.60M - Other current liabilities
€21.33M - Total current liabilities
€33.69M - Long-term debt
€4.33M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€273.59K - Total non-current liabilities
€4.60M - Total liabilities
€38.29M - Common stock
€14.67K - Retained earnings
-€377.66M - Other equity
€312.42K - Total equity
€666.35M - Total liabilities and shareholders' equity
€704.63M
Company information
- Market capitalization
€1.03B - Employees
163 - Enterprise Value
€1.16B
Company ratios
- Gross margin
-
0.0% - EBITDA margin
-
0.0% - EBIT margin
-
0.0% - EBT margin
-
0.0% - Net margin
-
0.0% - ROE
-
-23.2% Much better than peer group: -59.7% - ROA
-
-21.9% Much better than peer group: -48.6% - Asset turnover
-
0.0% - FCF margin
-
0.0% - FCF yield
-13.7% - Efficiency ratio
0.0% - Net sales per employee
-
€0.00 - Net income per employee
-
-€948.63K